Matches in Nanopublications for { ?s ?p "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP599253.RAbnivG-AW1fe4ovuMqaS0N8GYx-4qVXcv3nA3KtVu1gM130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599253.RAbnivG-AW1fe4ovuMqaS0N8GYx-4qVXcv3nA3KtVu1gM130_provenance.
- NP712124.RAsqzi95_ca8dW3wQgZsAO-YDj4QCI4Rsbmi01Skitj-M130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712124.RAsqzi95_ca8dW3wQgZsAO-YDj4QCI4Rsbmi01Skitj-M130_provenance.
- NP500090.RAaua9Tp8it22MBwCiko5Dp_Qhot3kP6EnYzksAVJqo54130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500090.RAaua9Tp8it22MBwCiko5Dp_Qhot3kP6EnYzksAVJqo54130_provenance.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.
- NP195073.RAF2vPAnaFayxgJNsefUve10X2cNu0Eg2zCta6WAaWetg130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP195073.RAF2vPAnaFayxgJNsefUve10X2cNu0Eg2zCta6WAaWetg130_provenance.
- NP409688.RAzOgO3gWz6lIGaOvRcVs88sMVuqXFZxj8-qKHN8IJOL0130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409688.RAzOgO3gWz6lIGaOvRcVs88sMVuqXFZxj8-qKHN8IJOL0130_provenance.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.
- NP877392.RAIrTNFPfcMMZdPo_eyS1UL8wFNN7gf6SdyGgsLuBbH1Y130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877392.RAIrTNFPfcMMZdPo_eyS1UL8wFNN7gf6SdyGgsLuBbH1Y130_provenance.